Closing Bell: Medexus Pharmaceuticals Inc down on Wednesday (MDP)

Medexus Pharmaceuticals Inc opened trading today at $2.21 and closed at $2.15. It traded at a low of $2.15 to a high of $2.22.

The price decreased -4.44% from the previous day's close of $2.25.

During the day across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.

Medexus Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker MDP.

A total of 20,700 shares was traded during the session, with total trades of 38, while having an average volume of 21,029 over the last 5-days.

Trading across the entire TSX saw 1,249 price advancers against 3,959 declines and 110 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have soared 3.86 percent in 52 weeks, while in 2024, they have dipped -12.96%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $55.03 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Medexus Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..